flolan
Generic: epoprostenol sodium
Labeler: glaxosmithkline llcDrug Facts
Product Profile
Brand Name
flolan
Generic Name
epoprostenol sodium
Labeler
glaxosmithkline llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
epoprostenol sodium 1.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0173-0519
Product ID
0173-0519_38b7a328-0fa3-409f-b230-16bcbc8f4798
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA020444
Marketing Start
1995-12-08
Marketing End
2026-05-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01730519
Hyphenated Format
0173-0519
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
flolan (source: ndc)
Generic Name
epoprostenol sodium (source: ndc)
Application Number
NDA020444 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1.5 mg/1
Packaging
- 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0173-0519-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "38b7a328-0fa3-409f-b230-16bcbc8f4798", "openfda": {"unii": ["4K04IQ1OF4"], "rxcui": ["211199", "211200", "562501", "562502"], "spl_set_id": ["8e4b636e-ee9c-4111-779d-28c8369d283b"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0173-0519-00)", "package_ndc": "0173-0519-00", "marketing_end_date": "20260531", "marketing_start_date": "19951208"}], "brand_name": "FLOLAN", "product_id": "0173-0519_38b7a328-0fa3-409f-b230-16bcbc8f4798", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Prostacycline Vasodilator [EPC]", "Prostaglandins I [CS]", "Vasodilation [PE]"], "product_ndc": "0173-0519", "generic_name": "epoprostenol sodium", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FLOLAN", "active_ingredients": [{"name": "EPOPROSTENOL SODIUM", "strength": "1.5 mg/1"}], "application_number": "NDA020444", "marketing_category": "NDA", "marketing_end_date": "20260531", "marketing_start_date": "19951208"}